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10-31 weeks the incidence of carcinoma was 65%. No
For a better understanding of carcinogenesis, mice models mutations were detected in the analysed oncogene and with targeted mutations in tumour suppressor or oncogenes tumour suppressor genes. Plasma TGF-β1 levels in IL-10-were generated. Although genetic alterations in mice and deficient mice 10-31 weeks old were higher than in wildhumans do not always result in the same type of tumours, the type littermates e.g. 45.7 ⍨ 4.6 ng/ml versus 19.8 ⍨ 4. 5 basic molecular mechanisms are often relevant for both species. ng/ml (P < 0.01). No alterations in K-ras, p53, Apc and IL-10-deficient mice develop colorectal carcinoma through the Msh2 genes suggests that other genes are involved in the dysplasia sequence, which is histologically similar to IBDdevelopment of these tumours. Elevated TGF-β1 plasma associated cancers in humans. The purpose of this study was levels correspond to the high incidence of dysplasia and firstly to identify the possible mutations of oncogenes and cancer. Normal expression of the TGF-β II receptors hints tumour suppressor genes involved in the induction and progresat genetic alterations in other members of the TGF-β sion of tumours in IL-10-deficient mice, and secondly to look receptor signal transduction pathway.
for similarities in genetic alterations involved in IBD-associated carcinomas between humans and this murine model.
Introduction
Materials and methods Interleukin-10-deficient mice, maintained under specificAnimals pathogen free (SPF) conditions, spontaneously develop chronic All animal experiments were investigated and approved by both the Animal enterocolitis, a condition phenotypically similar to chronic Ethic Committee of the University and the Ministry of Science prior to the inflammatory bowel disease (IBD) in humans (1), at 6 weeks studies (GZ 66.009/22). Interleukin 10 (-/-) mice generated on a C57BL/6 of age. Intensive study of these animals should lead to a better background (3) and wild-type (wt) littermate controls were purchased from understanding of the complex mechanisms involved in the B & K Universal (Hull, UK). Animals were kept under specific-pathogen free initiation and progression of IBD. Recently it has been shown (SPF) conditions and fed a standard diet and water ad libitum. All mice received human care in accordance with the National Institutes of Health that 6-month-old IL-10-deficient mice have a high incidence guidelines and the legal requirements in Austria.
of adenocarcinomas, which is mostly dependent on their Examination of mice genetic background (2) . We have observed that C57BL/6 mice The entire small and large intestine were examined in 48 IL-10 (-/-) and 14 IL-10 (ϩ/ϩ) mice between 9 and 31 weeks of age. Moribund IL-10 (-/-) Abbreviations: APC, adenomatous polyposis coli; FAP, familial adenomatous polyposis; HNPCC, hereditary nonpolyposis colorectal cancer; IBD, mice and age-matched wild-type mice were killed by cervical dislocation and then autopsied. The small and large intestines were fixed in PBS ϩ 4.5% inflammatory bowel disease; MMR, mismatch repair; PCR, polymerase chain reaction; SPF, specific-pathogen free; SSCP, single-strand conformation formaldehyde before embedding in paraffin blocks. For histological analysis, 5 µm thick sections were cut and stained with hematoxylin and eosin (H&E). polymorphism; TGF-β, transforming growth factor β. p53 exon 6  255  p53 intron 5S  5Ј-CCTCAACACCGCCTGTGGGGTTAG  p53 intron 6AS  5Ј-GAAAGTCAACATCAGTCTAGGCTG  p53 exon 7  234  MP7-56F  5Ј-CAGGTCACCTGTAGTGAGGTAGGG  MP7-56R  5Ј-TGGAACAGAAACAGGCAGAAGCTGG  p53 exon 8  269  p53 intron 7S  5Ј-TTTACACACAGTCAGGATGGGGCC  p53 intron 8AS 5Ј-AAGAGGTGACTTTGGGGTGAAGCTC K-ras codon 12-13 102 K12S (4-11) 5Ј-TATAAACTTGTGGTGGTTGGAGCT Histopathologically, dysplasia was classified as either low-grade or high-grade loaded onto a 0.8 mm thick 24ϫ18 cm, 7% non-denaturing polyacrylamide gel. Electrophoresis was performed in 1ϫ TBE buffer at 850 V/h at room according to Riddell et al. (4) .
temperature. DNA fragments were stained with Syber Green I (Novex, San DNA extraction Diego, CA) and visualized by UV under detector at 250 nm. The tumour tissue area and the adjacent area of normal intestinal tissue were Immunohistochemistry separately dissected under the microscope and collected in Eppendorf tubes. The genomic DNA was purified from these specimens using proteinase K Immunohistochemical staining was performed on 5 µm thick, formalin-fixed, lysis mix (50 mM Tris-HCl pH 8.0, 100 mM EDTA, 100 mM NaCl, 1% paraffin embedded tissue sections. Sections were deparaffinized in xylene, re-SDS, 500 µg/ml proteinase K). In brief, the sections were deparaffinized, hydrated in graded alcohols and washed in water. Antigen retrieval was rehydrated and treated with proteinase K lysis buffer overnight at 55°C, accomplished by microwave irradiation. After being blocked in 10% normal followed by centrifugation at 14 000 g for 20 min. The DNA from the horse/rabbit/goat serum for 15 min at room temperature, the serial sections supernatant was precipitated with 100% ethanol, washed with 75% ethanol, were incubated with one of the following primary antibodies, respectively: (i) dried and resuspended in dH 2 were treated with biotinylated secondary antibodies (Vector Laboratories, PCR-based non-radioactive single strand conformation polymorphism Burlingame, CA) for 30 min at room temperature, rinsed and incubated with ('cold' SSCP) was used to screen for the presence of p53 and K-ras avidin-biotin complex (Vectastain ABC Peroxidase kit; Vector Laboratories), mutations in tumours. Table I shows the sequence of four primers used in our for 45 min at room temperature. For visualization of rabbit anti-P53 polyclonal study. Genomic DNA (100 ng) was used as a template in a reaction volume antibodies, incubation with goat anti-rabbit secondary antibodies was followed of 25 µl containing 20 pmol each primer, 50 µM each dNTP and 1 U Golden by incubation with Strep-AB Complex/HRP (DAKO A/S Glostrup, Denmark), Taq DNA polymerase (Perkin Elmer, Foster City, CA). PCR reactions were for 30 min at room temperature. The peroxidase activity was visualized by carried out in a Perkin Elmer Thermal Cycler 480 for 45 cycles. Annealing application of the chromogen 3,3Ј-diaminobenzidine. The sections were then temperatures for each primer set were optimized in pilot studies before counterstained with hematoxylin, dehydrated, cleared and mounted. processing experimental samples. The PCR products were purified from primer For the detection of the APC protein we used APC (N-15), a rabbit dimers using the Concert Rapid PCR Purification System (Gibco BRL, polyclonal antibody raised against the N-terminus of the APC protein (Santa Rockville, MD) and analysed for yield and purity by electrophoresis on 10%
Cruz Biotechnology, Santa Cruz, CA), and APC (C-20), a rabbit polyclonal polyacrylamide mini gels (Novex, San Diego, CA). A 10 µl aliquot of purified antibody raised against the C-terminus of the APC protein (Santa Cruz PCR product mixed with loading buffer was heat denaturated by boiling for Biotechnology). Following removal of paraffin in xylene, tissue rehydration 5 min, placed immediately on ice and loaded on the gel. Either 20% (for exon was performed employing descending grades of alcohol (100-50%). The 7 of p53 and codon 12-13 of K-ras) or 4-20% gradient (for exon 6 and 8 of endogenous peroxidase activity was blocked by incubation with 0.6% H 2 O 2 p53) pre-cast polyacrylamide Tris/borate/EDTA (TBE) gels were used (Novex, in methanol for 30 min, followed by rinsing with running tap water. The San Diego, CA). Optimal temperatures and other electrophoretic conditions antigen retrieval was accomplished by treatment with 0.1% protease type XIV were empirically predetermined according to Hongyo et al. (5) . Electro-(Sigma, St Louis, MO) for 10 min at 37°C. The reaction was stopped by phoresis was run at constant voltage (300 V) on a Thermo Flow Electrophoresis washing twice in cold Tris-HCl buffer 7.4. Non-specific antigens were Temperature Control (ETC) System (Novex, San Diego, CA). Buffer temperablocked by pre-incubation with 10% normal goat serum for 15 min at room ture, gel type and fragment size determined the running time. Circulating temperature. The primary antibodies N-15 and C-20 were diluted 1:250 and TBE buffer was maintained at 8°C for exon 7 (p53) and codon 12-13 (K-1:50, respectively, in 0.5 M Tris-HCl buffer pH 7.5, containing 2% BSA ras), at 10°C for exon 6 (p53) and 24°C for exon 8 (p53). The gels were and applied for 1 h at room temperature. After brief washing, sections were stained with Syber Green II (Novex, San Diego, CA) and photographed under treated with biotinylated goat anti-rabbit IgG (Vector Laboratories) for 30 min UV light.
at room temperature. Additional washing was followed by incubation with Sequence analysis the avidin-biotin complex for 45 min at room temperature. The reaction was developed using the chromogen 3,3Ј-diaminobenzidine. SSCP data were verified by sequencing. Genomic PCR products of normal Detection of MSH2 proteins was performed with mouse monoclonal and tumour specimens were used as templates for direct sequencing. Prior to antibody (clone FE11; Calbiochem) diluted 1:5, following the procedure sequencing, the PCR products of p53 (exons 6-8) and K-ras (exon 1, described for Ab-3 and Ab-7 in P53 protein detection. codon 12-13) genes were purified from single-stranded DNA residues. The For the detection of the TGF-β1 II receptor we used TGF-β1 RII (C16), a sequencing reaction mixture consisted of 2 µl purified PCR product, 2 pmol rabbit polyclonal antibody raised against a peptide mapping within the Cprimer (sense or antisense) and 2 µl Terminator Ready Reaction Mix (Perkin terminal domain of the TGF-β1 II receptor (Santa Cruz Biotechnology). The Elmer Applied Biosystems), in a total volume of 10 µl. Sequencing was endogenous peroxidase was blocked by incubation with 0.6% H 2 O 2 in performed in a T1 thermocycler (Biometra, Goettingen, Germany) for 25 methanol for 30 min, followed by rinsing with tap water. After being blocked cycles of 10 s at 96°C, 5 s at 50°C and 4 min at 60°C. The product was in 10% normal goat serum for 15 min at room temperature, the sections were purified by precipitation in 75% isopropanol and analysed in a ABI Prism incubated overnight at 4°C with the primary antibody diluted 1:150. After 310 Genetic Analyser (Perkin Elmer, Foster City, CA).
brief washing, sections were treated with biotinylated goat anti-rabbit IgG Microsatellite instability in colorectal tumours (Vector Laboratories) for 30 min at room temperature, washed and incubated Tumour tissue and adjacent normal colonic tissue were analysed for microsatellwith Strep-AB Complex/HRP (DAKO A/S Glostrup, Denmark) for 30 min at ite instability at eight chromosomal loci: D17Mit123, D14Mit15, D10Mit2, room temperature. The immunoreaction was visualized using 3,3Ј-diaminoD7Mit91, D6Mit59, D4Mit27, D3Mit203 and D1Mit36. Microsatellite primer benzidine. sequences were obtained from the Whitehead Institute for Genome Research
Analysis of TGF-β1 levels (Cambridge, MA). Five of these amplify sequences containing CA repeats, and the other three (D4Mit27, D3Mit203, D1Mit36) amplify loci containing Immediately prior to being killed, mice were anaesthesized with phenobarbital (35 mg/kg body weight) and bled from the heart. Plasma with a low platelet GT repeats. PCR products (12 µl) were mixed with 5 µl loading buffer and metastasis in mesenteric lymph nodes and liver were observed at this age.
Analysis of K-ras and p53 mutations
Twenty colorectal tumours were screened for the presence of activating mutations in codon 12-13, using PCR-based cold SSCP method and sequencing. Surprisingly, there were no K-ras point mutations in any of the tumours examined (Figure 3) .
To analyse whether the overexpression of the P53 protein correlates with the initiation and progression of colorectal tumours in IL-10 (-/-) mice, we used one type of monoclonal antibody and two types of anti-P53 polyclonal antibodies. None of the examined tumours showed positive staining, indicating that there was no overexpression of P53 protein.
Among the variety of mutations which inactivate p53, point mutations at exons 6-8 tend to predominate. Each of the colorectal DNA samples were examined by cold SSCP analysis of exons 6-8 of the p53 gene. There was no altered electrophoretic mobility in any of the examined PCR products ( Figure  4 ) and sequencing revealed no mutations.
APC mutation
The status of the APC protein in colorectal tumours in IL-10 (-/-) mice was analysed using monoclonal antibodies specific for the N-and C-terminus of APC. Immunohistochemical staining showed no difference between tumour and adjacent normal colonic tissue ( Figure 5 ).
Microsatellite instability
To analyse the stability of microsatellite sequences from both tumours and the surrounding normal colonic tissue, eight different sets of primers were used. As shown in Figure 6 , none of the samples show any change in dinucleotide repeat sequences, indicating no microsatellite instability in tumours developed in IL-10 (-/-) mice. To determine MSH2 expression, all tumours were subjected Please note enlarged and irregular colonic crypts. The nuclei atypia. H&E.
MSH2 expression in colorectal carcinomas
to immunohistochemical analysis using a mouse anti-MSH2
Original magnification, ϫ200.
polyclonal antibody. All examined specimens showed nuclear staining both in the tumour and the surrounding normal tissue. count was obtained according to the manufacturer and stored at -80°C. Plasma levels of TGF-β1 were measured by enzyme-linked immunosorbent assay, Plasma TGF-β1 levels in IL-10-deficient mice using a Human TGF-β1 Immunoassay kit (R&D System, Minneapolis, MN).
Plasma TGF-β1 levels in IL-10 (-/-) mice of age 10-31 weeks
The sensitivity of the assay was Ͻ7 pg/ml. were higher (45.7 Ϯ 4.6 ng/ml) than in wild-type littermates All experiments were statistically analysed by the JMP program (Macintosh (19.8 Ϯ 4.5 ng/ml), P Ͻ 0.01 (Figure 7) . IL-10 (-/-) mice version). Evaluation of changes in cytokine concentrations was done by ANOVA and the Newman-Keuls multiple range test. All significance limits of age 10-31 weeks showed 8-fold higher TGF-β1 plasma were determined at the 99 percent confidence level.
concentrations (45.7 Ϯ 4.6 ng/ml) than those aged 5-7 weeks (5.5 Ϯ 1.6 ng/ml), P Ͻ 0.01. These dramatic increases are Results associated with the incidence of dysplasias and cancers in examined mice.
Development of colorectal dysplasias and carcinomas in IL-10-deficient mice Expression of the TGF-β II receptor Histological analysis showed that in contrast to wild-type
To examine the expression of the TGF-β II receptor in tumour littermates at the age of 9 weeks, all IL-10 (-/-) mice developed tissue, all tumours were analysed with monoclonal antibodies colitis. We have also observed that the small intestine was not specific for the C-terminus of the TGF-β II receptor. Immunoaffected, and there was no histological difference of the small histochemical staining showed no difference between tumour intestine between IL-10 (-/-) and IL-10 (ϩ/ϩ) animals. At 9 and adjacent normal colonic tissue. weeks, 13 out of 22 animals (59%) suffering from colitis developed high grade dysplasia (Figure 1 ) and 3 animals Discussion (14%) were found to have adenocarcinomas. In 10-31-weekold mice, the incidence of colorectal carcinomas was much
In our study we have observed that IL-10-deficient mice, although kept under SPF conditions, suffer from colitis from higher, e.g. 17 out of 26 animals (65%), suggesting rapid progression of dysplasias to carcinomas (Table II) . Some 6 weeks of age. They develop high grade dysplasia at 9 weeks and finally cancer. According to our data, it seems that the tumours infiltrated the muscularis propria (Figure 2 ) but no We have also observed the high similarities in the histopatho-M, DNA molecular weight marker; WT, wild type; Mu, mutated; Ca, logical pattern of colorectal cancers between IL-10-deficient cancer. There is no altered electrophoretic mobility in any of the tumour samples.
mice and IBD-associated carcinomas in humans. Both of them develop from flat dysplastic epithelium rather than from adenomas. According to these findings, it might be possible occurrence of dysplasia and cancer in IL-10-deficient mice is not dependent on the genetic background, as previously that the genetic alterations involved in tumorigenesis are similar too. To gain further insight into the molecular basis of believed (2) . The relatively short period between development of colitis with dysplasia and carcinoma (6 versus 9 weeks) in carcinogenesis in these mice we have analysed 20 colorectal tumours for mutations in the KRAS, p53, APC, MSH2 and these animals, makes it hardly possible to follow up the chronic inflammation for a long period of time. Also, this event may TGF-β receptor II genes and microsatellite instability; all of them known to have an important role in the initiation and result in these mice being unresponsive to different types of therapy against chronic inflammation. From our data we can progression of familial, sporadic and IBD-associated tumours.
Mutations of the K-Ras oncoprotein occur in 40-60% of confirm that IL-10-deficient mice may be considered as an appropriate animal model for the study of IBD; however, only sporadic colorectal cancers. The single point mutations occurring at codons 12 and 13 or 61 are an early event in the for a short period of time. After that, the possible development of dysplasia and cancer should be kept in mind in any kind development of sporadic colorectal carcinomas. However, the role of KRAS in IBD-associated carcinomas is not clearly of experiments using this model. mice, used in our study, are considered as strain 'resistant' to K-ras mutations (11) .
Inactivation of the p53 tumour suppressor gene is one of the most frequent mutations occurring in 70% of sporadic colorectal carcinomas and about 50% of IBD-associated colorectal carcinomas in humans. Genetic alterations of p53 in sporadic colorectal carcinoma are reported as a late event, whereas in the case of IBD-associated carcinomas there is conflicting evidence as to whether p53 mutations are early (13) or late event (14) . The inactivation of p53 fits in with the 'two hits' hypothesis which includes allelic loss in the p53 gene followed by the missense mutation in the other allele. The oncogenic potential of a p53 mutation is not only due to the tumour suppressive function but also to the dominant negative effect which is caused by the dimerization of mutant p53 with the wild-type protein. This drives the wild-type into the mutant conformation. Both events result in nuclear or cytoplasmatic accumulation of mutated protein, which can be detected by immunohistochemistry. Although we examined exons would lead to inactivation of p53, we used the immunohistochemical method to visualize mutated protein. This method did not detect any mutations of p53 in the examined tumours either. A possible explanation for this result might be the fact that p53 null or heterozygous mice (p53 ϩ/-) develop soft tissue sarcomas, osteosarcomas and lymphomas rather than carcinomas (15) . These findings, together with the previous reports of the rare occurrence of p53 mutations in chemically-induced lung and liver tumours, as well as intestinal tumours of Apc null mice, lead to the suggestion that p53 mutations are not involved in malignant transformation of epithelial cells in mice. Also, inactivation of p53 may occur in the late stage of colorectal cancers developing in IL-10-deficient mice, thus being present in a small number of tumour cells and barely detectable by the methods used in our study. Another possible reason might be that mutations at other exons mutations.
Germline mutations of APC occur in 90% of adenomatous polyps, developed through FAP. Somatic mutations of the APC defined. Previous studies have shown either a high (up to 40%) (6), or rather low (5-8%) incidence of KRAS mutations gene are also found in 60% of sporadic colon cancers as well as intestinal tumours from patients suffering from hereditary (7). In order to determine the role of K-ras mutations in the development of colorectal cancers in this model, we used the non-polyposis colorectal cancer (HNPCC). In general, the frequency of the APC gene attenuation is similar in sporadic SSCP method to detect single point mutations of codons 12 and 13; reported as the most frequently mutated codons (8) .
colorectal adenomas and cancers, indicating that the APC mutation represents an early event in the development of No mutations were detected in the K-ras oncogene exon 1 (codons 12 and 13). In previous reports, K-ras mutations were sporadic and familial colorectal cancers. The incidence of APC mutations in IBD-associated cancer is much lower (6%) than present at a high percentage in chemically induced prostate adenocarcinoma, in neurogenic sarcomas in rats (9) and mouse in sporadic tumours (16) , showing that this genetic change is not involved in the initiation of IBD-associated carcinogenesis lung tumours (10) . Our data are in accordance with the results of Smits et al. (11) who showed a lack of ras mutations in but more possibly occurs in the later stages. Most of the identified APC mutations (Ͼ95%), both germ-line and somatic intestinal tumours from Apc1638N, a mouse model for Apcdriven carcinogenesis. Similar data were shown in chemically mutation result in a truncated APC protein (17). In our study, we have used immunohistochemistry in order to detect this induced mouse stomach tumours (12) . There seems to be evidence that gastrointestinal cancers in mice are not driven truncated APC protein. The results also show that APC mutations are not involved in the initiation of cancer, which by ras mutations. However, to confirm this hypothesis other members of the ras family, namely Hras and Nras, have to is in accordance with previous reports concerning mutations in carcinomas developed through the dysplasia sequence (16). be analysed in our model as well. Another reason for the lack of K-ras mutations might be due to the mice strain. C57BL/6
Germline mutations of mismatch repair genes (MMR), hMLH1, hPMS1, hPMS2 and hMSH2, are responsible for ability to maintain the epithelial tissue organization. However, HNPCC (18). In tumours, the wild-type allele is lost through our results show that despite elevated TGF-β levels, 31% of allelic loss or mutational inactivation. Somatic mutations IL-10 deficient mice develop dysplasia and 65% cancer. Our (including allele loss) inactivating both mismatch repair alleles findings are in line with the fact that 20% of Rag -/-Tgf-β ϩ/ϩ have also been reported in 20% of sporadic colorectal cancers mice develop cancer as well. This demonstrates that normal (19). Previous studies showed that tumours with the MMR as well as elevated TGF-β levels are not enough to prevent gene mutation display genetic instability characterized by dysplasia as the consequence of chronic inflammatory stress alteration in microsatellites. The microsatellite instability in these animals. phenotype was defined in neoplastic (20) and non-neoplastic
To examine whether the unresponsiveness of tumours to tissue from patients with ulcerative colitis (21). Although at elevated levels of TGF-β is due to decreased expression of present, it is not clear whether this phenotype is caused the TGF-β II receptor, all tumour specimens were analysed by genetic alterations of MMR genes (22), or by chronic immunohistochemically. Immunohistochemical results showed inflammation, which can damage DNA over a long period of that, in IL-10-deficient mice, downregulation and truncation time, thus exceeding the capacity of the DNA repair machinery of the TGF-β II receptor is not the reason for the resistance and resulting in gene mutations causing genetic instability (23).
of tumours to the growth-inhibitory effects of TGF-β1. Previous In our study, none of the tumours showed microsatellite reports have also shown that the loss of TGF-β receptors is instability at any of the loci examined. Immunohistochemical not an exclusive event causing tumour proliferation (26). examination did not show a truncation mutation of the MSH2
According to this we believe that in our model the tumour protein either, although it was shown that MSH2-deficient development involves a receptor downstream mechanism; mice develop intestinal tumours. A possible reason for the including alterations of one of the members in the signal lack of microsatellite instability might be that in IL-10-deficient transduction pathway, activated through the TGF-β family mice the genomic instability during tumorigenesis is due to receptors. Some of the most interesting candidates for future chromosomal instability caused by chronic inflammation rather analysis are the members of the SMAD family, SMAD2, than to microsatellite instability. SMAD3 and SMAD4. It has been suggested that SMAD2, Increased plasma levels of TGF-β1 corresponding to the located on chromosome 18q21, is one of the tumour suppresage and occurrence of dysplasia and colorectal cancers in ILsor genes mutated in human sporadic colorectal carcinomas 10-deficient mice is consistent with previous data, which (27) . Mutations in the SMAD4 (DPC4) gene, located on showed an increase of plasma TGF-β1 levels in patients the same chromosome, have also been found in colorectal suffering from colorectal cancer (24). The TGF-β family carcinomas (28). Germline mutation of SMAD4 has also been consists of multifunctional polypeptides known to regulate cell described in familial juvenile polyposis, an autosomal dominant proliferation, cell differentiation, adhesion and migration. TGFsyndrome that predisposes the patient/host to hamartomatous β appears to be one of the most potent negative growth polyps and gastrointestinal cancers (29) . In addition, heteroregulators for epithelial cells, especially for the intestinal zygous inactivation of Smad4 in mice caused gastrointestinal epithelium. It has been suggested that TGF-β is a physiological polyposis similar to human juvenile polyps (30). Mutations in modulator of normal intestinal epithelial growth, probably Smad3 are not associated with human cancer. Zhu et al. acting in an autocrine fashion. The role of TGF-β in tumour (31) showed that SMAD3-deficient mice develop colorectal development seems to be dual, and dependent on the stage of carcinoma. Interestingly, both SMAD3 and IL-10-deficient the tumour. Thus TGF-β may act as a tumour suppressor in mice develop colorectal cancers, but without neoplastic lesions the earliest stages of carcinogenesis, but it can stimulate in the small intestine. In addition, the lack of TGF-β II receptor invasiveness later on. This may be related to the loss of tumour downregulation and truncation in IL-10-deficient mice may responsiveness on the growth inhibitory effect of TGF-β and suggest also a possible involvement of a pathway independent at the same time to the TGF-β induced angiogenesis, and local of TGF-β1, which may affect the same cellular process affected and systemic immunosuppression. It has been shown that by TGF-β. TGF-β has an important immunomodulatory role acting either Despite the high similarities between the histopathological as an initiator or suppressor of the immune response. One of pattern of colorectal cancers in IL-10-deficient mice and IBDthe anti-inflammatory roles of TGF-β is the inhibition of the associated carcinomas, no correlation in genetic alterations has respiratory burst of macrophages and the suppression of TNF-α led us to the conclusion that IL-10-deficient mice are not an and other pro-inflammatory cytokines. The increased level of appropriate model for investigating IBD-associated carcinoplasma TGF-β1 in IL-10-deficient mice may be one way the genesis. However, the finding that there are no mutations of animal tried to 'compensate' for the missing anti-inflammatory the known oncogenes or suppressor genes in IL-10-deficient cytokine IL-10. The fact that the overexpression of TGF-β1 mice also tells us that some other undiscovered genes are in plasma occurred at the same age in mice as the occurrence involved in the development of these tumours. This makes of dysplasia and cancers, led us to the conclusion that the IL-10-deficient mice even more of an interesting model for elevated level was also an attempt to inhibit these events.
novel insight into tumorigenesis. Looking for mutations of The importance of TGF-β tumour suppressor activity was new genes downstream in the TGF-β receptor cascade will demonstrated by Engle et al. (25) who showed a high incidence give us a better understanding of mechanisms involved in the of inflammation-associated cancer in Tgf-β -/-Rag -/-mice. pathogenesis of neoplastic lesions. Similar to our findings, those cancers also did not show microsatellite instability or mutations of the Apc gene,
